Dextra Laboratories

For the total GMP synthesis of complex carbohydrates and carbohydrate based medicinal chemistry, Dextra has a proven record of developing innovative solutions to minimise costs, reduce technology transfer issues and optimise robust route generation. Custom Synthesisfrom mgs to multi kg scale, core capabilities include: Process development, glycosylation, hydrogenation and conjugation chemistry. Analytical Servicesproviding comprehensive analytical support for custom synthesis programs and independent analytical services GMP API Manufacturingto support Phase I and Phase II clinical trials in reactors up to 50 L Dextra Catalogueshowcases a range of over 800 carbohydrate products, including neoglycoproteins, neoglycolipids, heparin derivatives, iminosugars, blood group products, oligosaccharides,...

Carbohydrate synthesis,iminosugars,gmp and cmc documentation,and clinical trial support

Dextra laboratories operates in the Biotechnology research industry.

Dextra laboratories's revenue is 11m - 100m

Dextra laboratories has 11 - 50 employees.